References
Brentjens MH, Yeung-Yue KA, Lee PC, et al. Recurrent genital herpes treatments and their impact on quality of life. Pharmacoeconomics 2003; 21 (12): 853–63.
Taboulet F, Halioua B, Malkin JE. Quality of life and use of health care among people with genital herpes in France. Acta Derm Venereol 1999; 79 (5): 380–4.
Doward LC, McKenna SP, Kohlmann T, et al. The international development of the RGHQoL: a quality of life measure for recurrent genital herpes. Qual Life Res 1998; 7 (2): 143–53.
Centers for Disease Control and Prevention. Diseases characterized by genital ulcers. Sexually transmitted diseases treatment guidelines. MMWR Recomm Rep 2002; 51 (RR-6): 11–25.
Association for Genitourinary Medicine (AGUM), Medical Society for the Study of Venereal Disease (MSSVD). 2002 national guideline for the management of genital herpes [online]. Available from: URL: http://www.agum.org.uk [Accessed 2003 Oct31]
Leung DT, Sacks SL. Current recommendations for the treatment of genital herpes. Drugs 2000; 60 (6): 1329–52.
British National Formulary No. 46 [online]. Available from URL: http://www.bnf.org [Accessed 2003 Nov 21]
Carney O, Ross E, Ikkos G, et al. The effect of suppressive oral acyclovir on the psychological morbidity associated with recurrent genital herpes. Genitourin Med 1993; 69 (6): 457–9.
Patel R, Tyring S, Strand A, et al. Impact of suppressive antiviral therapy on the health related quality of life of patients with recurrent genital herpes infection. Sex Transm Infect 1999; 75 (6): 398–402.
Romanowski B, Marina RB, Roberts JN, et al. Patients’ preference of valacyclovir once-daily suppressive therapy versus twice-daily episodic therapy for recurrent genital herpes: a randomized study. Sex Transm Dis 2003; 30 (3): 226–31.
Benedetti J, Corey L, Ashley R. Recurrence rates in genital herpes after symptomatic first-episode infection. Ann Intern Med 1994; 121 (11): 847–54.
Patel R, Boselli F, Cairo I, et al. Patients’ perspectives on the burden of recurrent genital herpes. Int J STD AIDS 2001; 12 (10): 640–5.
Mertz GJ, Benedetti J, Ashley R, et al. Risk factors for the sexual transmission of genital herpes. Ann Intern Med 1992; 116 (3): 197–202.
Corey L, Tyring S, Beutner K, et al. Once daily valaciclovir reduces transmission of genital herpes [abstract LB-3]. 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC); 2002 Sep 27–30; San Diego
Benedetti JK, Zeh J, Corey L. Clinical reactivation of genital herpes simplex virus infection decreases in frequency over time. Ann Intern Med 1999; 131 (1): 14–20.
Rights and permissions
About this article
Cite this article
Suppressive antiviral therapy improves quality of life in patients with recurrent genital herpes. Drugs Ther. Perspect 20, 23–26 (2004). https://doi.org/10.2165/00042310-200420030-00008
Published:
Issue Date:
DOI: https://doi.org/10.2165/00042310-200420030-00008